Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. Phase 3 clinical data demonstrated significant improvements in glycaemic control and body weight in research populations. Supplied as a 10 mg lyophilised research vial at ≥99% HPLC purity.
Add 2 mL bacteriostatic water for 5,000 mcg/mL.
Use our peptide reconstitution calculator →
Store lyophilised at −20 °C. Reconstituted: 4 °C, use within 21 days.
Every NewChem batch of Tirzepatide is independently tested prior to dispatch. Your COA documents HPLC purity (≥99%), identity confirmation via mass spectrometry, endotoxin screening, and a unique batch ID for full traceability. Sample COAs are available on request before purchase.
For a detailed step-by-step reconstitution guide for Tirzepatide, including BAC water measurements, syringe unit conversions, and storage protocols, see our dedicated guide:
